The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 22, Pages 8612
Publisher
MDPI AG
Online
2020-11-17
DOI
10.3390/ijms21228612
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Is Low Alveolar Type II Cell SOD3 in the Lungs of Elderly Linked to the Observed Severity of COVID-19?
- (2020) Ahmed S. Abouhashem et al. ANTIOXIDANTS & REDOX SIGNALING
- Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost
- (2020) Manar Mohammed El Tabaa et al. BIOCHEMICAL PHARMACOLOGY
- COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
- (2020) Tomasz J Guzik et al. CARDIOVASCULAR RESEARCH
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- COVID-19 infection: the perspectives on immune responses
- (2020) Yufang Shi et al. CELL DEATH AND DIFFERENTIATION
- The Science Underlying COVID-19: Implications for the Cardiovascular System
- (2020) Peter P. Liu et al. CIRCULATION
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- (2020) Wen Zhang et al. CLINICAL IMMUNOLOGY
- Autocrine Bradykinin Release Promotes Ischemic Preconditioning-Induced Cytoprotection in Bovine Aortic Endothelial Cells
- (2020) Alessandro Bellis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19
- (2020) Ishan Paranjpe et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
- (2020) Tao Chen et al. BMJ-British Medical Journal
- Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
- (2020) Shaobo Shi et al. JAMA Cardiology
- Neprilysin inhibitor–angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients
- (2020) Domenico Acanfora et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Molecular immune pathogenesis and diagnosis of COVID-19
- (2020) Xiaowei Li et al. Journal of Pharmaceutical Analysis
- Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
- (2020) Sebastián Ibáñez et al. CLINICAL RHEUMATOLOGY
- The ACE2‐deficient mouse: A model for a cytokine storm‐driven inflammation
- (2020) Junyi Wang et al. FASEB JOURNAL
- Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality
- (2020) Feng Zhou et al. HYPERTENSION
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Relation of Statin Use Prior to Admission to Severity and Recovery Among COVID-19 Inpatients
- (2020) Lori B. Daniels et al. AMERICAN JOURNAL OF CARDIOLOGY
- Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
- (2020) Brett L Houston et al. Clinical Trials
- Imaging Diagnostics and Pathology in SARS-CoV-2-Related Diseases
- (2020) Manuel Scimeca et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effectiveness of remdesivir for the treatment of hospitalized COVID‐19 persons: A network meta‐analysis
- (2020) Yawen Jiang et al. JOURNAL OF MEDICAL VIROLOGY
- Unfractionated heparin inhibits live wild type SARS‐CoV‐2 cell infectivity at therapeutically relevant concentrations
- (2020) Julia A. Tree et al. BRITISH JOURNAL OF PHARMACOLOGY
- Acute Infection and Myocardial Infarction
- (2019) Daniel M. Musher et al. NEW ENGLAND JOURNAL OF MEDICINE
- C-type natriuretic peptide co-ordinates cardiac structure and function
- (2019) Amie J Moyes et al. EUROPEAN HEART JOURNAL
- Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial
- (2019) David A Morrow et al. EUROPEAN HEART JOURNAL
- Mitochondrial angiotensin receptors and cardioprotective pathways
- (2019) Nelson Escobales et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
- (2018) Eric J. Velazquez et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2017) Borja Ibanez et al. EUROPEAN HEART JOURNAL
- Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides
- (2017) Emilia D'Elia et al. EUROPEAN JOURNAL OF HEART FAILURE
- Low molecular weight heparins prevent the induction of autophagy of activated neutrophils and the formation of neutrophil extracellular traps
- (2017) Angelo A. Manfredi et al. PHARMACOLOGICAL RESEARCH
- The Metalloprotease Neprilysin Degrades and Inactivates Apelin Peptides
- (2016) Shaun M. K. McKinnie et al. CHEMBIOCHEM
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens
- (2016) Michele Senni et al. EUROPEAN JOURNAL OF HEART FAILURE
- Salt Sensitivity of Blood Pressure
- (2016) Fernando Elijovich et al. HYPERTENSION
- Racial Differences in Natriuretic Peptide Levels
- (2015) Deepak K. Gupta et al. JACC-Heart Failure
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atrial natriuretic peptide inhibits lipopolysaccharide-induced acute lung injury
- (2014) Takashi Nojiri et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Atrial Natriuretic Peptide–Mediated Inhibition of Microcirculatory Endothelial Ca 2+ and Permeability Response to Histamine Involves cGMP-Dependent Protein Kinase I and TRPC6 Channels
- (2013) Wen Chen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Efficacy of Low Molecular Weight Heparin in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Receiving Ventilatory Support
- (2013) Yongbing Qian et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- NH 2 -Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes
- (2013) Mariana Lazo et al. DIABETES
- Unfractionated heparin inhibits lipopolysaccharide-induced inflammatory response through blocking p38 MAPK and NF-κB activation on endothelial cell
- (2012) Xu Li et al. CYTOKINE
- Phosphorylation of GSK-3β Mediates Intralipid-induced Cardioprotection against Ischemia/Reperfusion Injury
- (2011) Siamak Rahman et al. ANESTHESIOLOGY
- Gastrin-releasing peptide receptor (GRPR) mediates chemotaxis in neutrophils
- (2011) R. S. Czepielewski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enhancing the Outcome of Cell Therapy for Cardiac Repair
- (2010) Emmanouil Chavakis et al. CIRCULATION
- Heparin Enhances Serpin Inhibition of the Cysteine Protease Cathepsin L
- (2009) Wayne J. Higgins et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFα
- (2009) Junjie Xing et al. MICROVASCULAR RESEARCH
- SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway
- (2008) Hongliang Wang et al. CELL RESEARCH
- Cardioprotection
- (2008) Gerd Heusch et al. CIRCULATION
- Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes
- (2008) O. Kunduzova et al. FASEB JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started